Assessment of Dissociative Traumatic Disorders (TEDI)

May 6, 2020 updated by: Januel

More than 70% of ambulatory patients with IDD have attempted suicide (APA, 2015). This disorder, as well as all the disorders on the dissociation spectrum, must therefore be clarified and better diagnosed.

The goal of this research is :

  1. to assess the prevalence of dissociative disorders using specific tools in patients suffering from PTSD.
  2. to validate the French version of the DDIS interview (Ross, 1997) that the investigators have translated.

Study Overview

Status

Unknown

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Île De France
      • Neuilly Sur Marne, Île De France, France, 93330
        • Recruiting
        • Youcef Bencherif
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patient diagnosed with PTSD according to DSM 5 criteria
  • Over 18 years of age
  • Informed consent signed

Exclusion Criteria:

  • Neurological disorders
  • Serious and/or unstable somatic pathologies
  • Patient not affiliated with social security
  • Patient hospitalized under restraint in psychiatric care by decision of the state representative or in psychiatric care at the request of a third party
  • Patient under guardianship
  • Patient participating in parallel in another biomedical research
  • Change of antidepressant in the last three months
  • Patient not mastering the French language

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Posttraumatic stress disorder
cohort of patients with Posttraumatic stress disorder PTSD
Self assessment for the passing of the following rating scales CTQ-SF36-ITQ-PCL5-DES Hetero-assessment for the pasing of the following rating scales DDIS FR and medical interview

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post Traumatic Stress
Time Frame: 1 year
assessment of the prevalence of dissociative disorders in a cohort of patients with PTSD
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Khalid KALALOU, Psychiatrist, EPS Ville Evrard

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 5, 2019

Primary Completion (Anticipated)

September 5, 2020

Study Completion (Anticipated)

September 5, 2021

Study Registration Dates

First Submitted

April 29, 2020

First Submitted That Met QC Criteria

May 6, 2020

First Posted (Actual)

May 7, 2020

Study Record Updates

Last Update Posted (Actual)

May 7, 2020

Last Update Submitted That Met QC Criteria

May 6, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Posttraumatic Stress Disorder

Clinical Trials on self-assessment and hetero-assessment

3
Subscribe